Navigation Links
Chimerix to Present at Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference
Date:7/20/2011

DURHAM, N.C., July 20, 2011 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer, will participate on a panel at Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference on July 22nd, 2011, 10:30 am ET. The conference is being held at the Almas Temple Club in Washington, D.C. on July 20-22, 2011, and will provide vital information about new public health initiatives to facilitate growth in the nation's biodefense medical countermeasures pipeline.

Dr. Painter will participate on a panel entitled: "New Approaches to Drug Resistance and Emerging Infectious Disease," which will focus on the challenge of drug resistance and the public health threats posed by emerging infectious diseases. Discussion topics will include Chimerix's antiviral development efforts, key challenges that biotechnology companies face in addressing drug resistance, and what companies are looking to obtain from the government and other partners to overcome this challenge.

Chimerix's lead compound, CMX001, is being developed as a potential broad spectrum oral antiviral for the treatment of life-threatening double-stranded DNA (dsDNA) viral diseases, including herpes viruses, adenoviruses and orthopox viruses. CMX001 is also being developed as a biodefense countermeasure in the event of a smallpox release. The growing body of evidence of CMX001's antiviral activity against all five families of dsDNA viruses that cause morbidity and mortality in humans, including smallpox, has strengthened the compound's potential as a dual-use product prescribed as a traditional pharmaceutical and stockpiled as a biodefense countermeasure. To date, more than 550 patients have been dosed with CMX001 in ongoing placebo-controlled clinical trials and in open-label treatment protocols for the prophylaxis, preemption and treatment of dsDNA viru
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Chimerix Appoints Timothy W. Trost Senior Vice President, Chief Financial Officer
2. Chimerix to Present at Cowen and Company 31st Annual Health Care Conference
3. Disseminated Adenovirus Infection Eradicated in a Pediatric Hematopoietic Stem Cell Transplantation Recipient Who Received Chimerixs Lead Antiviral CMX001
4. Chimerix to Present at the Citi 2011 Global Health Care Conference
5. Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
6. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
7. Chimerix to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
8. Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
9. Chimerix to Present at 9th Annual BIO Investor Forum
10. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
11. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015  Kannalife Sciences, Inc. ("Kannalife") announces that ... Scientific Advisory Board to assist the Company in the ... use of cannabinoid therapeutics for the treatment of Chronic ... responsible for conducting the full autopsy of Mike ... for the Pittsburgh Steelers. It was through his examination ...
(Date:3/4/2015)... , Mar. 04, 2015 Research and Markets ... addition of the "Negative Pressure Wound Therapy ... Global Industry Analysis, Size, Share, Growth, Trends and ... offering. , The global negative ... types and by geography. By product types the ...
(Date:3/4/2015)... , March 4, 2015 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... company will participate in the upcoming 27 th ... Dana Point, CA.  Dr. ... of Oramed, will present a corporate overview on March ...
Breaking Medicine Technology:Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 2Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 3Global Negative Pressure Wound Therapy (Conventional and Single Use NPWT Systems) Market Report 2014-2020 2Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3
... California and AMSTERDAM, July 21, 2011 , ... in,molecular cancer diagnostics, announced today that, together with,thought-leading ... has launched the RATHER (Rational Therapy for,Breast Cancer) ... will collectively receive nearly €12,million in funding from ...
... MEADVILLE, Pa., July 21, 2011 C&J Industries announced today the ... expansion. With these 2 Phases complete, C&J now has three Class ... Molding presses. These presses range in size from 20 Ton, ... the machines are Toshiba all-electric presses. C&J has also ...
Cached Medicine Technology:Agendia Receives €1.27 Million in Funding from the EU's Seventh Framework Programme 2Agendia Receives €1.27 Million in Funding from the EU's Seventh Framework Programme 3C&J Industries Completes Phases I and II of Building Expansion 2
(Date:3/4/2015)... California (PRWEB) March 04, 2015 RapidScale, ... 2015, in Las Vegas, Nevada, on March 16th-18th. They ... RapidScale will have some of its top engineering executives ... advances in the RapidScale solution set. Attendees include William ... Senior Cloud Engineer; and Ryan Turpin, Cloud Support Manager. ...
(Date:3/4/2015)... Information Innovators Inc . (Triple-i) ... has joined the company as Chief Technology Officer. Mr. ... for the company, including customer-centric strategies and initiatives, and ... of experience as a technology executive and visionary. Prior ... the FBI including oversight of enterprise data management, analytic ...
(Date:3/4/2015)... 04, 2015 Plungerhead has ... service members during and after their service to the ... increase awareness through advertising, social media and several national ... patriotic organization through a special retail promotion of Plungerhead ... March through May 2015. , “There is a ...
(Date:3/4/2015)... WASHINGTON, DC (PRWEB) March 04, 2015 ... announced additional discussion leaders for its upcoming fifth ... 2015 in Paris, France. The event this year ... from more than 20 of the field’s leading ... will bring together top executives and clinical researchers ...
(Date:3/4/2015)... Saint Petersburg, Florida and Dayton, Ohio (PRWEB) March 04, ... who was nearly killed in an IED explosion in ... went through while recovering. He received some free Chiropractic ... was introduced to Magnetic Resonance Therapy. , This is ... beginning treatment using the Magnesphere, I have clarity, I ...
Breaking Medicine News(10 mins):Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 2Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 3Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 2Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 3Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 2Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 3
... government Wednesday amended the rules governing the private educational ... them.// ,The state cabinet decided to adopt ... students and employees, an official said here. ... adequate infrastructure to students, pay prescribed and timely salaries ...
... study has indicated that inflammatory bowel disease in women could ... times.// , ,Diseases such as Crohn's disease and ulcerative ... babies or premature babies. Yet, the 'silver lining' exists in ... certainly reduced the risks. ,The St. Mary's ...
... issue of the medical journal Otolaryngology- Head and Neck Surgery ... long-term hearing loss that can be caused by exposure to ... the impact of “impulse noise” (short bursts of acoustic energy) ... using short-term exposure to the impulse noise generated by five ...
... bread developed by Researchers at the Food Technology Plant ... people suffering from celiac disease// otherwise called as gluten ... resulting product is known to have enhanced nutritive value ... the permanent intolerance of gluten, forcing sufferers to follow ...
... For plenty of good reasons, the term “trans fat” ... consumers. Typically, trans fatty acids are bad for health, ... Agriculture have coaxed out significant health benefits by juggling ... Proctor, professor of food science, and graduate student Vishal ...
... Dr Choong-Siew Yong, today urged Australians to spare a thought ... ,'This time of year for most people means ... spells only isolation and despair,' Dr Yong said. ... the new year can cause depression for those who are ...
Cached Medicine News:Health News:Gluten Free Bread: Boon for Celiac Disease 2Health News:Healthy Potato Chips: A Trans Fat Oil With Health Benefits 2
... (bDNA) delivers unmatched precision and reproducibility, so you ... viral load values they can trust.,you detect significant ... critical decision points - without the variability seen ... to choose VERSANT HIV bDNA, consider this: it's ...
... an FDA-approved HIV-1 RNA assay, is utilized for ... the regulatory approval for HIV-1 therapies, and is ... laboratories worldwide. , The AMPLICOR HIV-1 ... acid amplification test for the quantification of Human ...
... a single use rapid test, for the detection ... whole blood (venipuncture). Uni-Gold Recombigen HIV is intended ... an aid in diagnosis of infection with HIV-1. ... multi-test algorithms designed for the statistical validation of ...
The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple...
Medicine Products: